Form D · Pharmaceuticals
Phlow Corp.
Richmond, VA · CIK 0001832917
Offering snapshot reported Feb 14, 2025 · SEC filing
- Reported sold
- $30.5M Offering amount: $40M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 31, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 14, 2025 | Initial | $30,527,397 | No comparison | 9 | SEC filing |
| Jul 10, 2024 | Initial | $5,000,000 | No comparison | 1 | SEC filing |
| Sep 2, 2022 | Initial | $24,200,000 | No comparison | 11 | SEC filing |
| Nov 20, 2020 | Initial | $15,000,000 | No comparison | 4 | SEC filing |
| Nov 18, 2020 | Initial | $0 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-538322
The Total Offering Amount and Total Amount Sold include the amount of the principal and accrued interest on a convertible note that elected to convert into equity issued in the offering.
Source: Form D, filed Feb 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ron Barden | Executive |
| Robert Demeria | Executive |
| Eric Edwards | Director, Executive |
| Glenn Gerecke | Executive |
| Rosemary Gibson | Director |
| Bernard Gupton | Director |
| Daniel Hackman | Executive |
| Melinda Hancock | Director |
| Kerry Ingalls | Director |
| David Levin | Executive |
| James Robert Mooney | Executive |
| Anna Maria Nekoranec | Director |
| Thomas O'malley | Director |
| David Ryan | Executive |
| Andrew Stiles | Executive |
| Marshall Summar | Director |
| Martin Van Trieste | Director |
| Guido Villax | Director |
| Elizabeth Whalley | Executive |
| Elizabeth Whalley Buono | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
424 Hull Street Suite 400
Richmond, VA, 23224
Phone: 804-207-4893
Richmond, VA, 23224
Phone: 804-207-4893